Received Feb 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPAB | HEP A + HEP B (TWINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | m4b34 | IM / UN |
Patient submitted to receive her second dose a week after her first. This was flagged in our corporate system and I was notified to verify the patient's records to determine if she received the first dose. Upon investigation on state shots, it was determined the patient received 3 doses of hepA/hepB (twinrix) back in 2012 and 2013 to complete the series. The dose she recently received on 2/7/25 was a revaccination that the guidelines do not recommend at this time.